Experience of Glatiramer Acetate in the Treatment of Relapsing-Remitting Multiple Sclerosis Patients

Experience of Glatiramer Acetate in the Treatment of Relapsing-Remitting Multiple Sclerosis Patients

Show other versions (1)

OBJECTIVE: Glatiramer acetate (GA) has been shown to reduce the number of relapses and improve outcomes in relapsing-remitting multiple sclerosis (RRMS) patients. The aim of this study is to investigate the efficacy and side effects of GA in RRMS patients treated with it. METHODS: We retrospectivel...

Full description

Bibliographic Details
Main Authors: Özlem Taşkapılıoğlu, Aslı Bahar Turan, Murat Albas, Ömer Faruk Turan
Format: Article
Language:English
Published: Galenos Yayinevi 2012-03-01
Series:Türk Nöroloji Dergisi
Subjects:
Multiple sclerosis
relapsing-remitting
immunomodulatory therapy
glatiramer acetate
Online Access:http://www.tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-64325

Internet

http://www.tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-64325

Similar Items